FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010493468> ?p ?o ?g. }

• W2010493468 abstract "Several studies report the use of tumor necrosis factor alpha (TNF-alpha) inhibitors in refractory hidradenitis suppurativa (HS), particularly infliximab and etanercept. However, very limited data have been reported for adalimumab, the newest fully human anti-TNF-alpha monoclonal antibody. We evaluated the long-term efficacy and safety of adalimumab therapy in 6 patients with refractory HS. In the case of positive culture findings from any draining lesion, antibiotic therapy was administered for at least 2 weeks before initiating adalimumab therapy. Adalimumab (in 40-mg subcutaneous injections) was prescribed every other week. If the disease was inadequately controlled, the dosage was increased to 40 mg/wk. If HS was in persistent clinical remission, adalimumab therapy was gradually decreased to 40 mg every 3 weeks. Quality of life was assessed using the Dermatology Life Quality Index.Six patients (mean [SD] age, 39.3 [12.9] years) with severe HS (mean [SD] duration, 22.5 [11.7] years) were treated with adalimumab. Significant improvements after 1 month of treatment were seen in the Dermatology Life Quality Index; in the number of affected regions, nodules, and fistulas; and in the basic laboratory findings. Improvements were maintained for a mean (SD) follow-up of 21.5 (7.1) (range, 13-29) months. Adalimumab was well tolerated. Conclusion Adalimumab appears to be an effective and safe treatment for refractory HS." @default.
• W2010493468 created "2016-06-24" @default.
• W2010493468 creator A5013884928 @default.
• W2010493468 creator A5031531166 @default.
• W2010493468 creator A5046000172 @default.
• W2010493468 creator A5051334937 @default.
• W2010493468 creator A5064006101 @default.
• W2010493468 creator A5078531852 @default.
• W2010493468 creator A5082655077 @default.
• W2010493468 date "2009-05-01" @default.
• W2010493468 modified "2023-10-15" @default.
• W2010493468 title "Long-term Successful Adalimumab Therapy in Severe Hidradenitis Suppurativa" @default.
• W2010493468 cites W1978269870 @default.
• W2010493468 cites W1980685745 @default.
• W2010493468 cites W1999378785 @default.
• W2010493468 cites W2012847560 @default.
• W2010493468 cites W2031313786 @default.
• W2010493468 cites W2042195767 @default.
• W2010493468 cites W2046549669 @default.
• W2010493468 cites W2059461946 @default.
• W2010493468 cites W2066219225 @default.
• W2010493468 cites W2071893776 @default.
• W2010493468 cites W2080261485 @default.
• W2010493468 cites W2088744925 @default.
• W2010493468 cites W2093141131 @default.
• W2010493468 cites W2098105262 @default.
• W2010493468 cites W2103969062 @default.
• W2010493468 cites W2121565960 @default.
• W2010493468 cites W2127799105 @default.
• W2010493468 cites W2128583237 @default.
• W2010493468 cites W2139130283 @default.
• W2010493468 cites W2153656045 @default.
• W2010493468 cites W2161769425 @default.
• W2010493468 cites W2165385798 @default.
• W2010493468 cites W2172208853 @default.
• W2010493468 cites W3145922622 @default.
• W2010493468 cites W2161986081 @default.
• W2010493468 doi "https://doi.org/10.1001/archdermatol.2009.49" @default.
• W2010493468 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19451504" @default.
• W2010493468 hasPublicationYear "2009" @default.
• W2010493468 type Work @default.
• W2010493468 sameAs 2010493468 @default.
• W2010493468 citedByCount "75" @default.
• W2010493468 countsByYear W20104934682012 @default.
• W2010493468 countsByYear W20104934682013 @default.
• W2010493468 countsByYear W20104934682014 @default.
• W2010493468 countsByYear W20104934682015 @default.
• W2010493468 countsByYear W20104934682016 @default.
• W2010493468 countsByYear W20104934682017 @default.
• W2010493468 countsByYear W20104934682018 @default.
• W2010493468 countsByYear W20104934682019 @default.
• W2010493468 countsByYear W20104934682020 @default.
• W2010493468 countsByYear W20104934682021 @default.
• W2010493468 countsByYear W20104934682022 @default.
• W2010493468 crossrefType "journal-article" @default.
• W2010493468 hasAuthorship W2010493468A5013884928 @default.
• W2010493468 hasAuthorship W2010493468A5031531166 @default.
• W2010493468 hasAuthorship W2010493468A5046000172 @default.
• W2010493468 hasAuthorship W2010493468A5051334937 @default.
• W2010493468 hasAuthorship W2010493468A5064006101 @default.
• W2010493468 hasAuthorship W2010493468A5078531852 @default.
• W2010493468 hasAuthorship W2010493468A5082655077 @default.
• W2010493468 hasConcept C121332964 @default.
• W2010493468 hasConcept C126322002 @default.
• W2010493468 hasConcept C141071460 @default.
• W2010493468 hasConcept C142424586 @default.
• W2010493468 hasConcept C159110408 @default.
• W2010493468 hasConcept C16005928 @default.
• W2010493468 hasConcept C17991360 @default.
• W2010493468 hasConcept C2776002364 @default.
• W2010493468 hasConcept C2776173921 @default.
• W2010493468 hasConcept C2777138892 @default.
• W2010493468 hasConcept C2777226972 @default.
• W2010493468 hasConcept C2779134260 @default.
• W2010493468 hasConcept C2779951463 @default.
• W2010493468 hasConcept C2780132546 @default.
• W2010493468 hasConcept C71924100 @default.
• W2010493468 hasConcept C87355193 @default.
• W2010493468 hasConcept C90924648 @default.
• W2010493468 hasConceptScore W2010493468C121332964 @default.
• W2010493468 hasConceptScore W2010493468C126322002 @default.
• W2010493468 hasConceptScore W2010493468C141071460 @default.
• W2010493468 hasConceptScore W2010493468C142424586 @default.
• W2010493468 hasConceptScore W2010493468C159110408 @default.
• W2010493468 hasConceptScore W2010493468C16005928 @default.
• W2010493468 hasConceptScore W2010493468C17991360 @default.
• W2010493468 hasConceptScore W2010493468C2776002364 @default.
• W2010493468 hasConceptScore W2010493468C2776173921 @default.
• W2010493468 hasConceptScore W2010493468C2777138892 @default.
• W2010493468 hasConceptScore W2010493468C2777226972 @default.
• W2010493468 hasConceptScore W2010493468C2779134260 @default.
• W2010493468 hasConceptScore W2010493468C2779951463 @default.
• W2010493468 hasConceptScore W2010493468C2780132546 @default.
• W2010493468 hasConceptScore W2010493468C71924100 @default.
• W2010493468 hasConceptScore W2010493468C87355193 @default.
• W2010493468 hasConceptScore W2010493468C90924648 @default.
• W2010493468 hasIssue "5" @default.
• W2010493468 hasLocation W20104934681 @default.
• W2010493468 hasLocation W20104934682 @default.
• W2010493468 hasOpenAccess W2010493468 @default.

• next